HDFCG15ETF vs NIPPON INDIA PHARMA FUND
Portfolio Overlap Analysis · Nippon vs HDFC
19.4%
Low Overlap
4 common stocks · Rank #11471 of 28,282 pairs
Common Holdings (4)
| Stock | Wt% in HDFCG15ETF | Wt% in NIPPON INDIA PHARMA | Overlap |
|---|---|---|---|
Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology | 8.44% | 13.08% | 8.44% |
Divi's Laboratories Limited Pharmaceuticals & Biotechnology | 3.74% | 6.56% | 3.74% |
Apollo Hospitals Enterprise Limited Healthcare Services | 3.69% | 5.17% | 3.69% |
Cipla Limited Pharmaceuticals & Biotechnology | 3.48% | 5.67% | 3.48% |
Unique to HDFCG15ETF
- Mahindra & Mahindra Ltd.13.91%
- Infosys Limited12.84%
- Tata Consultancy Services Ltd.12.35%
- Hindustan Unilever Ltd.9.52%
- Maruti Suzuki India Limited8.94%
- Titan Company Ltd.8.19%
- TVS Motor Company Ltd.4.17%
Unique to NIPPON INDIA PHARMA
- Lupin Limited7.99%
- Dr. Reddy's Laboratories Limited5.81%
- MedPlus Health Services Limited3.70%
- Vijaya Diagnostic Centre Limited3.49%
- Max Healthcare Institute Limited3.49%
- Ajanta Pharma Limited3.41%
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology15.7% (3)
Healthcare Services3.7% (1)
Analysis
AI-generated comparative analysis coming soon.
More comparisons for HDFCG15ETF
- vs Nippon India ETF Nifty 50 Shar43.3% · 5 stocks
- vs SBI Nifty Consumption ETF36.0% · 8 stocks
- vs SBI Nifty India Consumption In36.0% · 8 stocks
- vs HDFC Nifty India Consumption I36.0% · 8 stocks
- vs NIPPON INDIA ETF NIFTY INDIA C35.9% · 8 stocks
More comparisons for NIPPON INDIA PHARMA
- vs HEALETF59.2% · 15 stocks
- vs NH55.9% · 14 stocks
- vs ICICI Prudential Pharma Health55.6% · 19 stocks
- vs ICICI Prudential Nifty Pharma 55.2% · 14 stocks
- vs SBI Healthcare Opportunities48.6% · 19 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.